Younger women with breast carcinoma have a poorer prognosis than older women.

Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (2000) 2.80

Breast cancer in young women: poor survival despite intensive treatment. PLoS One (2009) 2.36

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg (2009) 2.14

Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer (2004) 1.62

Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer (1996) 1.57

Geographic socioeconomic status, race, and advanced-stage breast cancer in New York City. Am J Public Health (2002) 1.52

Breast cancer in young women in a limited-resource environment. World J Surg (2010) 1.48

The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer. J Transl Med (2015) 1.41

Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). Br J Cancer (1999) 1.26

Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck (2013) 1.23

Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma. Mol Cancer (2008) 1.20

Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study. Eplasty (2010) 1.14

Renal cell carcinoma in young and old patients--is there a difference? J Urol (2008) 1.13

Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology (2008) 1.10

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One (2013) 1.07

Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg (2008) 1.03

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates? World J Surg Oncol (2007) 0.99

Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res (2005) 0.99

Prognostic significance of young age (<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry-based study. World J Surg (2011) 0.97

Pregnancy and breast cancer: a population-based study. Virchows Arch (2003) 0.96

Is surgical management compromised in elderly patients with breast cancer? Ann Surg (1997) 0.95

Debate: The biology of breast cancer in young women is unique. Oncologist (2013) 0.94

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer. Br J Cancer (2011) 0.93

Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer (2004) 0.93

Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed (2010) 0.92

Pathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study. BMC Res Notes (2011) 0.91

Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World J Surg Oncol (2004) 0.91

Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer (2011) 0.91

Long-term impact of the 70-gene signature on breast cancer outcome. Breast Cancer Res Treat (2014) 0.90

Unique features of young age breast cancer and its management. J Breast Cancer (2014) 0.89

Age at diagnosis and breast cancer survival in iran. Int J Breast Cancer (2012) 0.88

GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients. Breast Cancer Res (2007) 0.86

Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study. Oncologist (2014) 0.86

Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res (2010) 0.84

The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer. Int J Med Sci (2011) 0.83

Comparison of Clinical Features and Treatment Outcome of Breast Cancers in Young and Elderly Chinese Patients. Breast Care (Basel) (2011) 0.82

Breast carcinoma in young females below the age of 40 years: A histopathological perspective. South Asian J Cancer (2014) 0.82

Can breast self-examination continue to be touted justifiably as an optional practice? Int J Surg Oncol (2011) 0.81

Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival. Br J Cancer (1999) 0.80

Breast cancer in moroccan young women: a retrospective study. BMC Res Notes (2010) 0.79

Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients. Oncotarget (2015) 0.79

A retrospective comparative study of clinicopathological features between young and elderly women with breast cancer. Int J Clin Exp Med (2015) 0.79

Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 0.78

Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann Surg (1998) 0.78

Prognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expression. Oncol Lett (2014) 0.78

Parallel routes of human carcinoma development: implications of the age-specific incidence data. PLoS One (2009) 0.77

Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. Br J Cancer (2013) 0.77

Frequent loss of the BLID gene in early-onset breast cancer. Cytogenet Genome Res (2011) 0.77

The Effect of Young Age in Hormone Receptor Positive Breast Cancer. Biomed Res Int (2015) 0.76

Treatment of breast cancer in young women: do we need more aggressive therapies? J Thorac Dis (2013) 0.75

African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer. J Cancer (2016) 0.75

Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification. Radiat Oncol (2010) 0.75

Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 0.75

Breast cancer imaging: Mammography among women of up to 45 years. Pol J Radiol (2010) 0.75

Guideline conformity treatment in young women with early-onset breast cancer in Germany. Breast Care (Basel) (2014) 0.75

Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions. Eur J Hum Genet (2017) 0.75

Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysis. PLoS One (2012) 0.75

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol (2017) 0.75

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (2000) 5.53

Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med (1990) 2.54

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04

Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol (2001) 2.03

The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88

Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78

Anorectal melanoma. Cancer (1981) 1.77

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77

Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit Care Med (2000) 1.66

Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65

Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg (1996) 1.60

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49

Emergency abdominal wall reconstruction with polypropylene mesh: short-term benefits versus long-term complications. Ann Surg (1981) 1.44

Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44

Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathog (1990) 1.42

Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol (1995) 1.41

Salutary effects of ATP-MgCl2 on the depressed endothelium-dependent relaxation during hyperdynamic sepsis. Crit Care Med (1999) 1.40

What is a surgical oncologist? Ann Surg Oncol (1994) 1.40

T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40

Clinical decision-making in early breast cancer. Ann Surg (1993) 1.39

Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality. Am J Surg (1980) 1.38

The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res (1990) 1.36

Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg (1988) 1.34

Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine (2001) 1.31

Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30

Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24

Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg (1993) 1.24

Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22

Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22

Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21

Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20

Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol (1999) 1.19

Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19

Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg (2000) 1.19

A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg (1998) 1.17

Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore. Antimicrob Agents Chemother (1994) 1.17

17 beta-Estradiol normalizes immune responses in ovariectomized females after trauma-hemorrhage. Am J Physiol Cell Physiol (2001) 1.16

Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16

Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg (1990) 1.15

The change of beta-adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol (2000) 1.13

The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock (2000) 1.12

Totally implantable venous access system for cyclic administration of cytotoxic chemotherapy. Am J Surg (1984) 1.11

Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10

Sphincter-saving procedures for distal carcinoma of the rectum. Ann Surg (1989) 1.10

The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol (2000) 1.09

Testosterone and/or low estradiol: normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma (1998) 1.08

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08

Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07

The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg (1978) 1.06

Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res (1990) 1.06

Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer (2000) 1.05

Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol (1997) 1.05

Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05

Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg (1998) 1.05

National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer (2000) 1.05

Insight into the mechanism by which estradiol improves organ functions after trauma-hemorrhage. Surgery (2000) 1.03

Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res (1990) 1.03

Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02

Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg (1989) 1.01

Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00

Resuscitation after uncontrolled venous hemorrhage: Does increased resuscitation volume improve regional perfusion? J Trauma (1998) 1.00

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg (1998) 1.00

A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer. Breast Cancer Res Treat (1982) 1.00

Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J Trauma (1999) 0.99

Pleural mesothelioma. Cancer (1976) 0.99

The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues. Ann Surg (1992) 0.99

The split latissimus dorsi myocutaneous flap. Ann Plast Surg (1981) 0.98

Gastrointestinal malignancies in patients with celiac sprue. Am J Surg (1998) 0.98

Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97

Do female sex steroids adversely or beneficially affect the depressed immune responses in males after trauma-hemorrhage? Arch Surg (2000) 0.97

Correlation of estrogen, progesterone, and androgen receptors in breast cancer. Am J Surg (1989) 0.97

Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97

Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis (2000) 0.96

The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet (1975) 0.96

Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg (1984) 0.96

Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am (1996) 0.96

Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95

Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer (1980) 0.95

L-arginine: a unique amino acid for restoring the depressed macrophage functions after trauma-hemorrhage. J Trauma (1999) 0.95

Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin (1999) 0.95

Rectal injuries. J Trauma (1969) 0.94

The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg (1998) 0.93

Testosterone and estrogen differently effect Th1 and Th2 cytokine release following trauma-haemorrhage. Cytokine (2001) 0.93

Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg (1975) 0.93

Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer (1994) 0.92

Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol (2000) 0.92

Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer (1981) 0.92

Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer (1977) 0.91